Immunosuppressive Characteristics of Human AFP: Effect on Tests of Cell Mediated Immunity and Induction of Humam Suppressor Cells

References

• Bergstrand C. G., Czar B. Paper electrophoretic study of human fetal serum proteins with demonstration of a new protein fraction. Scand. J. Clin. Lab Invest. 1957; 9: 277–286
   PubMed Web of Science ®Google Scholar
• Alpert E., Drysdale J. W., Schur P. H., Isselbacher K. J. Human AFP: Purification and physical properties. Fed. Proc. 1971; 30: 246
   Google Scholar
• Ruoslahti E., Terry W. D. Alpha-fetoprotein and serum albumin show sequence homology. Nature 1976; 260: 804–805
   PubMedGoogle Scholar
• Ruoslahti E, Engvall E. Immunological cross reaction between alphafetoprotein and albumin. Proc. Natl. Acad. Sci. U.S.A. 1976; 73: 4641–4644
   PubMedGoogle Scholar
• Gitlin D., Boesman F I. Fetus-specific serum proteins in several mamals and their relation to human AFP. COT. Biochem. Physiol [B] 1967; 21: 327–336
   PubMed Web of Science ®Google Scholar
• Gitlin D., Biasucci A. Development of yG, yA, yM, BlC, BU, C′1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alphal-antitrypsin, orosomucoid, β-lipoprotein, alpha2-macroglobulin, and prealbumin in the conceptus. J. Clin. Invest. 1969; 48: 1433–1466
   PubMedGoogle Scholar
• Alpert E. Human alphal-fetoprotein (AFP): Developmental biology and clinical significance. Progress in Liver Diseases, H. Popper, F. Schaffner. Grune and Stratton Inc., New York 1976; Vol. V
   Google Scholar
• Murgita R. A., Tomasi T. B. Suppression of the immune response by alpha-fetoprotein. I. The effect of muse alpha-fetoprotein on the primary and secondary antibody response. J. b. Wed. 1975; 141: 269–286
   Google Scholar
• Murgita R. A., Tomasi T. B. Suppression of the immune response by alpha-fetoprotein. II. The effect of mouse alpha-fetoprotein on mixed lymphocyte reactivity and mitrogen-induced lymphocyte transformation. J. Exp. Med. 1975; 141: 440–452
   Web of Science ®Google Scholar
• Tomasi T. B., Dattwyler R. J., Murgita R. A., Keller R. H. Immuno suppression by alpha-fetoprotein. Trans. Assoc. Amer. Phys. 1975; 83: 293–299
   Google Scholar
• Keller R. H., Smrskill W. H.J., Genbel A. P., Shorter R. G., Tomasi T. B. Alpha-fetoprotein and suppression of cell mediated inmunity in chronic active liver disease. Gastroenterology 1976; 70: 901
   Google Scholar
• Sheppard H. W., Sell S., Trefts P., Bahu R. Effects of alpha-fetoprotein on murine immune responses. I. Studies on mice. J. Immunol. 1977; 119: 91–97
   Google Scholar
• Sell S., Sheppard H. W., Poler M. Effects of alpha-fetoprotein on murine innnune responses. II. Studies on rats. J. Imunol. 1977; 119: 98–103
   Google Scholar
• Yachnin S., Lester E. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies of in vitro inmunosuppression. Clin. Exp. Immunol. 1976; 26: 484–490
   PubMedGoogle Scholar
• Yachnin S. Demonstration of the inhibitory effect of human alpha–fetoprotein on in vitro transformation of human lymphocytes. Proc. Nat. Acad. Sci. U.S.A. 1976; 73: 2857–2861
   Google Scholar
• Littman B. H., Alpert E., Rocklin R. E. The effect of nurified alphafetoprotein on in vitro assays of cell-mediated immunity. Cell. Immonuology 1977; 30: 35–42
   PubMedGoogle Scholar
• Auer I. O., Kress H. G. Suppression of the primary cell-mediated immune response by human alpha1-fetoprotein in vitro. Cell. Immunol. 1977; 30: 173–179
   PubMedGoogle Scholar
• Nishi S. Isolation and characterization of a human fetal-alpha-globulin from the sera of fetuses and a hepatoma patient. Cancer. Res. 1970; 30: 2507–2513
   Google Scholar
• Ruoslahti E., Senpala V. Studies of carcino-fetal proteins: Physical and chemical properties of human alpha-fetoprotein. Int. J. Cancer 1971; 7: 218–228
   Google Scholar
• Weigand K., Alpert E., Isselhacher K. J. Human hepatocellular carcinoma derived cells in culture: Studies of albumin biosynthesis and secretion, Manuscript in preparation
   Google Scholar
• Alpert E., Feller E. R. Alpha-fetoprotein (AFP) in benign liver disease: Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology, in press
   Google Scholar
• Andres J. M., Lilly J. R., Altman R. P., Walker W. A., Alpert E. Alphal-fetoprotein in neonatal hepatohiliary disease. J. Ped. 1977; 91: 217–221
   Google Scholar
• Sheffer A. L., Rocklin R. E., Goetzl E. J. Immunologic components of hypersensitivity reactions to cromlyn sodium. N. Engl J. Med. 1975; 293: 1220–1224
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by conbining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 1968; 21(supplement 97)77–89
   Google Scholar
• Littman B. H., David J. R., Rocklin R. E. Migration inhibitory factor (MIF) and proliferative responses by human lymphocytes sub-populations separated by sheep erythrocyte rosette formation. Cell. Immunol. 1976; 24: 241–249
   Google Scholar
• Wands J. R., Perrotto J. L., Alpert E., Isselbacher K. J. Cell-mediated immunity in acute and chronic hepatitis. J. Clin. Invest. 1975; 55: 921–929
   PubMed Web of Science ®Google Scholar
• Shou L., Schwartz S. A., Good R. A. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J. Exp. Med. 1976; 143: 1100–1110
   PubMed Web of Science ®Google Scholar
• Menzoian J. O., Glasgow A. H., Nimberg R. D., Cooperband S. R., Schmid K., Saporoschetz I., Mannick J. A. Regulation of T lymphocyte function by immunoregulatory alpha-globulin (IRA). J. Immunol. 1974; 113: 266–273
   Google Scholar
• Ford W. H., Caspary E. A., Shenton B. Purification and properties of a lymphocyte inhibition factor from human serum. Clin. Exp. Immunol. 1973; 15: 169–179
   Google Scholar
• Mortensen R. F., Gewurz H. Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes. J. Immunol. 1976; 116: 1244–1250
   Google Scholar
• Voorting-Hawking M., Michael J. G. Isolation and characterization of immunoregulatory factors from normal human serum. I. Preliminary Biological characterization of immunosuppressive factors. J. Immunol. 1977; 118: 505–513
   Google Scholar
• Occhino J. C., Glasgow A. H., Cooperband S. R., Mannick J. A., Schmid K. Isolation of an immunosuppressive peptide fraction from human plasma. J. Immunol. 1973; 110: 685–694
   Google Scholar
• Nelken D. Normal immunosuppressive protein (N.I.P.). J. Immunol. 1973; 110: 1161–1162
   Google Scholar
• Stimson W. H. Studies on the immunosuppressive properties of a pregnancy-associated alpha-macroglobulin. Clin. Exp. Immunol. 1976; 25: 199–206
   PubMed Web of Science ®Google Scholar
• Chiu K. M., Mortensen R. F., Osmand A. P., Gewurz H. Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness. Immunology 1977; 32: 997–1005
   PubMed Web of Science ®Google Scholar
• Curtis L. K., Edgington T. S. Regulatory serum lipoproteins: Regulation of lymphocyte stimulation by a species of law density lipoprotein. J. Immunol. 1976; 116: 1452–1458
   Google Scholar
• Chisari F. V., Routenberg J. A., Fiala M., Edgington T. S. Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis. J. Clin. Invest. 1977; 59: 134–142
   PubMed Web of Science ®Google Scholar
• Stimson W. H., Blackstock J. C. Identification of an immunosuppressive factor in pregnancy serum. Obstet. Gynecol. 1976; 48: 305–311
   Google Scholar
• Charpentier B., Guttmann R. D., Shuster J., Gold P. Augmentation of proliferation of human mixed lymphocyte culture by human alpha-fetoprotein. J. Immunol. 1977; 119: 897–900
   PubMedGoogle Scholar
• Lester E. P., Miller J. R., Yachnin S. A postsynthetic modification of human alpha-fetoprotein controls its immunosuppressive potency. Proc. Natl. Acad. Sci. U.S.A. 1977; 71: 3988–3992
   Google Scholar
• Alpert E., Drysdale J. W., Isselbacher K. J., Schur P. H. Human alpha-feotprotein. Isolation, characterization, and demonstration of microheterogeneity. J. Biol. Chem. 1972; 247: 3792–3798
   PubMed Web of Science ®Google Scholar
• Alpert E., Drysdale J. W., Isselbacher K. J. Isoelectric focusing of human alpha-fetoprotein: An aid in purification and characterization of microheterogeneity. Ann. N.Y. Acad. Sci. 1973; 209: 387–396
   Google Scholar
• Ruoslahti E., Seppala M., Pihko H., Vuopio P. Studies of carcino-fetal proteins. II. Biochemical comparison of AFP from human fetuses and patients with hepatocellular cancer. Int. J. Cancer 1971; 8: 283–288
   Google Scholar
• Goeken N. E., Thompson J. S. Conditions affecting the immunosuppressive properties of human alpha-fetoprotein. J. Immunol. 1977; 119: 139–142
   PubMed Web of Science ®Google Scholar
• Hersch E. M., Harris J. E. Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes. J. Immunol. 1968; 100: 1184–1194
   PubMedGoogle Scholar
• Nelson R. D., Lcu R. W. Macrophage requirement for production of guinea pig migration inhibition factor (MIF) in vitro. J. Immunol. 1975; 114: 606–609
   Google Scholar
• Twomey J. J., Razar S., Rocklin R. E. Human cells required for macrophage migration inhibitory factor (MIF) production. Clin, Immunol. Immunopath. 1977; 8: 396–404
   Google Scholar
• Rocklin R. E., MacDermott R. P., Chess L., Schlossman S. F., David J. R. Studies on mediator production by highly purified human T and B lymphocytes. J. Exp. Med. 1974; 140: 1303
   PubMed Web of Science ®Google Scholar
• Murgita R. A., Goidl E. A., Kontiainen S., Wigzell H. Alpha-fetoprotein induces suppressor T cells in vitro. Nature 1977; 267: 257–259
   Google Scholar
• Gitlin D., Perricelli A., Gitlin J. D. The presence of serum alpha-fetoprotein in sharks and its synthesis by fetal gastrointestinal tract and liver. Comp. Biochem. Physiol. 1973; 46B: 207–215
   Google Scholar
• Citlin D. Normal biology of alpha-fetoprotein. Ann. N.Y. Acad. Sci. 1975; 259: 7–16
   Google Scholar
• Silverstein A. M., Parshall C. J., Prendergast R. A. Studies on the nature of immunologic immaturity. Ontogeny of Immunity, R. T. Smith, R. A. Good, P. A. Miescher. University of Florida Press, Gainesville 1967; 143–149
   Google Scholar
• Carr M. C., Stites D. P., Fudenberg H. H. Cellular immune aspects of the human fetal-maternal relationship III. Mixed lymphocyte reactivity between related maternal and cord blood lymphocytes. Cell Immunol. 1974; 11: 332–341
   Google Scholar
• Olding L. B., Oldstone M. B.A. Lymphocytes from human newborns abrogate mitosis of their mother's lymphocytes. Nature 1974; 249: 161–162
   PubMed Web of Science ®Google Scholar
• Moretta L. Active thymus derived suppressor lymphocytes in human cord blood. Nature 1977; 269: 333–335
   Google Scholar
• Pena H., Petty W. M., Rocklin R. E. Suppression of maternal responsiveness to paternal antigens by maternal sera. J. Immunol. 1975; 114: 525–528
   Google Scholar
• Kasakura S. A factor in maternal plasma during pregnancy that suppresses the reactivity of mixed leukocyte cultures. J. Immunol. 1971; 107: 1296–1301
   PubMed Web of Science ®Google Scholar
• Rocklin R. E., Kitzmiller J. L., Carpenter C. B., Garovoy M. R., David J. R. Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. New. Engl. J. Med. 1976; 295: 1209–1213
   PubMedGoogle Scholar
• Primack A., Vogel C. L., Barker L. F. Immunological studies in Ugandan patients with hepatocellular carcinoma. Brit, Med. J. 1973; 1: 16–19
   PubMedGoogle Scholar